Trade Pfizer ^PFE

Pfizer (PFE) and Iron Mountain (IRM) lead the Bull Strangle watch list for this week

Goldman Sachs Healthcare Stocks: Top 10 Stock Picks

China Obesity Approval Puts Pfizer's GLP 1 Bet In Sharper Focus

Top Pharmaceutical Stocks To Watch Today - March 14th - Stock Observer

Ossiam Sells 4,709,790 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Marathon Capital Management

Integral Health Asset Management LLC Trims Holdings in Pfizer Inc. $PFE - Stock Observer

Fairfax Financial Holdings Ltd. Can Buys 240,000 Shares of Pfizer Inc. $PFE - Stock Observer

Comerica Bank Sells 48,571 Shares of Pfizer Inc. $PFE - Stock Observer

Symbol: ZPFE Security name: Pfizer (PFE) BMO CDR (CAD Hedge

Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma

Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript

AI in Life Sciences Market, 2026-2040 Industry Trends and Global Forecasts - IBM, IQVIA and Oracle Lead Data Platforms While Roche, Pfizer and AI Startups Accelerate Drug Discovery Innovation

SeaCrest Wealth Management LLC Has $1.66 Million Stake in Pfizer Inc. $PFE - Daily Political

Martingale Asset Management L P Has $12.88 Million Stock Holdings in Pfizer Inc. $PFE - Daily Political

PENBRAYA (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F | Valuespectrum.com

Building a gene editing lexicon: a model for rare and inherited disorders

Pfizer (NYSE:PFE) Shares Down 1.7% - Here's Why

Rep. Gilbert Ray Cisneros, Jr. Buys Shares of Pfizer Inc. (NYSE:PFE) - Daily Political

BridgeBio Pharma CEO Teases Pipeline Launches, Attruby Momentum, and Pfizer Tafamidis Trial Update - Daily Political

Dividend-paying pharma stock looks poised for a comeback, charts show

Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story

Promising Pharmaceutical Stocks To Watch Now - March 12th - Stock Observer

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

How Investors Are Reacting To Pfizer (PFE) Phase 2 Win For Tilrekimig In Atopic Dermatitis

Pfizer Inc. $PFE Shares Sold by SevenBridge Financial Group LLC - Markets Daily

The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income

Mackenzie Financial Corp Raises Holdings in Pfizer Inc. $PFE

How Tilrekimig's Trispecific Eczema Data At Pfizer (PFE) Has Changed Its Investment Story

Pfizer's Weight Management Drug Wins China Approval

Franklin Resources Inc. Raises Stock Holdings in Pfizer Inc. $PFE - Daily Political

Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case

ctDNA and tumor-based biomarkers of giredestrant response in acelERA breast cancer

Seroprevalence of anti-AAV antibodies in a healthy adult Spanish population: findings from the SAAVIA study

651,996 Shares in Pfizer Inc. $PFE Bought by Kepler Cheuvreux Suisse SA

MNCs, Indian drugmakers diverge to mutual gain: How win-win is it? - Rediff.com

Richard Bernstein Advisors LLC Sells 65,636 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer Tariff Exemptions And US$70b Pledge Reshape Valuation Debate

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

B cell imprinting in children impairs antibodies to the haemagglutinin stalk

Does Olema Pharmaceuticals (OLMA) Still Stand Apart After Roche's Breast Cancer Trial Setback?

Pfizer (NYSE:PFE) Trading 1.2% Higher - Time to Buy?

Pfizer (NYSE:PFE) Trading 1.2% Higher - What's Next? - Daily Political

Pfizer Inc. $PFE Shares Bought by Causeway Capital Management LLC

Neumega (Pfizer, (Wyeth Pharmaceuticals)) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Natixis Advisors LLC Has $44.06 Million Stock Holdings in Pfizer Inc. $PFE - Markets Daily

Comirnaty (Pfizer, BioNTech: Tozinameran) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Health experts discuss new biosimilar treatments for patients in Việt Nam

Banque Cantonale Vaudoise Sells 92,252 Shares of Pfizer Inc. $PFE

Legal & General Group Plc Purchases 3,296,415 Shares of Pfizer Inc. $PFE - Stock Observer

Van ECK Associates Corp Sells 4,744,499 Shares of Pfizer Inc. $PFE - Daily Political

Natixis Advisors LLC Sells 522,523 Shares of Pfizer Inc. $PFE - Stock Observer

GIPR antagonists reported in Pfizer patent | BioWorld

Artifacts worth millions sold illegally in Nanjing Museum scandal

Diagnostic uncertainty of clinical T2 disease and its impact on treatment stratification in upper tract urothelial carcinoma: a multicenter retrospective study

Pfizer (PFE) Valuation Check After New Tilrekimig Phase 2 Success And Pipeline Progress

Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight

Factbox-Global drugmakers rush to boost US presence as tariff threat looms

Trumenba (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Abrysvo or Arexvy Market Research Report 2026: Epidemiology, Pipeline Analysis, Leading Companies, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Pfizer's Tilrekimig Successfully Reduces Eczema Symptoms in Mid-Stage Trial, ETPharma

Prevnar Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Swiss National Bank Trims Stake in Pfizer Inc. $PFE

Schroder Investment Management Group Sells 203,688 Shares of Pfizer Inc. $PFE - Markets Daily

562,908 Shares in Pfizer Inc. $PFE Bought by WINTON GROUP Ltd

Pfizer: Tilrekimig Antibody Phase 2 Study Meets Primary Goal In Moderate To Severe Atopic Dermatitis

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

LGT Group Foundation Buys 423,419 Shares of Pfizer Inc. $PFE

Roche Stock Plummets as Giredestrant Fails Breast Cancer Trial, ETPharma

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Roche shares dip as oral breast cancer drug fails trial

Brokerages Set Pfizer Inc. (NYSE:PFE) PT at $28.05 - Stock Observer

Olema falls on Roche breast cancer failure with giredestrant | BioWorld

LGT Group Foundation Has $54.02 Million Holdings in Pfizer Inc. $PFE - Daily Political

Why the Manufacturing and the Regulatory Guidance of mRNA Vaccines Matters

Promising Dividend Stocks To Follow Today - March 8th - Markets Daily

How Apellis Adding Ex-Pfizer R&D Chief Mikael Dolsten to Its Board Will Impact Apellis (APLS) Investors - Simply Wall St News

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript

Crabel Capital Management LLC Takes Position in Pfizer Inc. $PFE - Markets Daily

Blair William & Co. IL Sells 437,039 Shares of Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Neo Ivy Capital Management - Stock Observer

Gamco Investors INC. ET AL Reduces Stock Position in Pfizer Inc. $PFE - Daily Political

Ibuzatrelvir potently reduced viral RNA levels despite a high rate of anti-S seropositivity: a post hoc analysis of serology of the phase 2b study

Pharmaceutical Stocks To Research - March 7th - Stock Observer

Dividend Stocks To Follow Today - March 7th - Daily Political

HUB Investment Partners LLC Buys 24,843 Shares of Pfizer Inc. $PFE - Stock Observer

Munich Reinsurance Co Stock Corp in Munich Purchases Shares of 1,584,714 Pfizer Inc. $PFE - Daily Political

Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement

Pfizer (NYSE:PFE) Shares Up 1.7% - What's Next?

Pfizer Leans On Cancer And Obesity Drugs For Future Growth

Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Steven A. Cohen, Warren Buffett, Scott Bessent, Sabal Capital Management, Point72 Asset Management, GeneDx Holdings Corp (WGS), DXP Enterprises Inc (DXPE), and More

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk